ImmunoGen Inc (NASDAQ:IMGN)
| 5.66 Delayed Data As of 3:59pm ET |  +0.13 / +2.35%Today’s Change | 3.38 Today|||52-Week Range 10.88 | -12.25% Year-to-Date |
Latest IMGN News | Press Releases
| Analysts Estimate ImmunoGen (IMGN) to Report a Decline in Earnings: What to Look Out for Jul 23 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 5.53 |
| Today’s open | 5.58 |
| Day’s range | 5.53 - 5.72 |
| Volume | 59,377 |
| Average volume (3 months) | 1,832,729 |
| Market cap | $1.1B |
Data as of 3:59pm ET, 07/28/2021
Growth & Valuation
| Earnings growth (last year) | +64.12% |
| Earnings growth (this year) | -213.78% |
| Earnings growth (next 5 years) | +15.00% |
| Revenue growth (last year) | +60.81% |
| P/E ratio | NM |
| Price/Sales | 8.59 |
| Price/Book | 12.17 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| SRRKScholar Rock Holding... | +2.96 | +9.23% |
| AGENAgenus Inc | +0.27 | +5.42% |
| PGENPrecigen Inc | +0.27 | +4.98% |
| STOKStoke Therapeutics I... | +1.02 | +3.52% |
Data as of 3:59pm ET, 07/28/2021
Financials
| Next reporting date | July 30, 2021 |
| EPS forecast (this quarter) | -$0.18 |
| Annual revenue (last year) | $132.3M |
| Annual profit (last year) | -$44.4M |
| Net profit margin | -33.54% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Waltham, Massachusetts |
Forecasts
